Abstract
Administration of growth hormone (GH) in IVF program has been employed to provide benefit among poor responders. In our phase I study, 0-264 ASRM 2012, the use of GH in poor responders was demonstrated to improve pregnancy rate. The aim of the consecutive study is to compare the efficacy of co-treatment with GH in poor responders and normal responder without co-treatment with GH.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
